Clinical Trial.jpeg

About Amador

We Are Here For You

Amador's VISION is to become a leading global partner to the success of novel and improved biotherapeutics through our MISSION of leveraging Amador expertise, reputation, and business ecosystem to provide global-standard services to biopharmaceutical companies. Amador VALUES excellence in operations, quality in our deliverables, unity in our team, courage, and integrity. Along with requiring dignity & respect for others, we encourage our employees to collaborate, find innovative solutions, constantly expand their knowledge & comfort zone, as well as compete to win.


Meet Our
Core Team of Professionals

Our consulting team is composed of dedicated professionals bringing a wealth of industry experience in all service areas we offer. Our team brings a level of knowledge and expertise to your project that ensures advanced, cross-functional support for your ongoing drug development and regulatory support activities. We also offer Project Management and additional services.


Bing Wang, PhD

  • Grey LinkedIn Icon

Cofounder, CEO


Rong Zeng, PhD

  • Grey LinkedIn Icon

Cofounder, COO


Xiaomin Chen, MS

  • Grey LinkedIn Icon

Cofounder, Senior Vice President


Haifeng Bao, PhD

  • Grey LinkedIn Icon

Transitional Medicine Lead


Rakesh Dixit, PhD, DABT

  • Grey LinkedIn Icon

Scientific Advisor, Safety and Toxicology Assessments


Kamille O'Connor, BS, PMP

  • Grey LinkedIn Icon

Director, Scientific Writing and Project Management


Ryan Criste, PharmD

  • Grey LinkedIn Icon

Director, Clinical Pharmacology


Ye Lu, MS

  • Grey LinkedIn Icon

Associate Director, Clinical Pharmacology


Nancy Zheng, PhD

  • Grey LinkedIn Icon

Associate Director,
Clinical Pharmacology


Huali Wu, PhD

  • Grey LinkedIn Icon

Associate Director, Pharmacometrics


Yue Jayde Jin, MS

  • Grey LinkedIn Icon

Associate Director, Biostatistics and Programming


Nicole Zane, PharmD, PhD

  • Grey LinkedIn Icon


Our Story

Finding Inspiration in Every Turn

Amador Bioscience, Inc. (US) was established in 2018 by the merger of Alpha Pharma (2016-2018) and Lucid CPS LLC (2017-2018) and provides mainly pharmaceutical consulting services. We provide consultation and clinical/entry declaration services, for both major pharmaceutical companies and small biotech startups, in clinical pharmacology, bioanalysis, and translational medicine, and also provide regulatory submission and supervision services for other CROs and consulting firms.

Amador's China facility is located in CHITIC Science & Technology Park, Hangzhou, China. The design, construction, and decoration of internal facilities comply with international first-class laboratory and office area standards. The laboratory is equipped with international advanced analytical devices, standard equipment, and operating system. The office area is open and bright with several sound-proof meeting rooms. Amador China provides clinical trial management, PK/ADA/Biomarker blood sample analysis, data processing, computer modeling, clinical reporting, and registration services for innovative biopharma worldwide.


We plan to open additional US facilities, including a laboratory, in late 2021.